Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK, Dynavax To Partner On TLR Compounds In Autoimmune, Inflammatory Disease

Dec 18 2008

Related Content

End of an Era for GSK and Exelixis

Nov 01 2008

Dynavax’s Vasculitis Case With Heplisav Could Be Random

Sep 18 2008

Love The One You’re With: BMS Pays Exelixis $240M Upfront In New Cancer Drug Deal

Dec 12 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window